581 896

Cited 0 times in

소아 성장호르몬결핍증 치료에 사용되는 성장호르몬 서방형 주사제의 경제성 평가

DC Field Value Language
dc.contributor.author김덕희-
dc.date.accessioned2015-04-24T17:29:17Z-
dc.date.available2015-04-24T17:29:17Z-
dc.date.issued2009-
dc.identifier.issn1738-1061-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/105492-
dc.description.abstractPURPOSE: From a societal perspective, we evaluated the cost-effectiveness of a novel sustained-release injection of recombinant human growth hormone (GH) administered on a weekly basis compared with that of the present daily GH injection for the treatment of children with GH deficiency. METHODS: Health-related utility for GH therapy was measured based on the visual analogue scale. During July 2008, caregivers of 149 children receiving GH therapy form 2 study sites participated in a web-based questionnaire survey. The survey required the caregivers to rate their current subjective utility with daily GH injections or expected utility of weekly GH injections. Because there was no difference in the costs of the daily and weekly therapies, for the purposes of this study, only drug acquisition costs were considered. RESULTS: Switching from daily to weekly injection of GH increased the utility from 0.584 to 0.784 and incurred an extra cost of 4,060,811 Korean won (KW) per year. The incremental cost-utility ratio (ICUR) for a base case was 20,305,055 KW per quality-adjusted life year (QALY) gained. Scenario analyses showed that the ICUR ranged from 15,751,198 to 25,489,929 KW per QALY. CONCLUSION: The ICUR for a base case and worst case scenario analyses ranged from 0.85 to 1.37-times per capita gross domestic product of Korea, which is considered to be within the generally accepted willingness-to-pay threshold. Thus, it is concluded that switching from daily to weekly injection of GH would be cost-effective.-
dc.description.statementOfResponsibilityopen-
dc.format.extent1249~1259-
dc.languageKorean-
dc.publisher대한소아과학회-
dc.relation.isPartOfKorean Journal of Pediatrics-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title소아 성장호르몬결핍증 치료에 사용되는 성장호르몬 서방형 주사제의 경제성 평가-
dc.title.alternativeEconomic evaluation of a weekly administration of a sustained-release injection of recombinant human growth hormone for the treatment of children with growth hormone deficiency-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pediatrics (소아과학)-
dc.contributor.googleauthor강혜영-
dc.contributor.googleauthor김덕희-
dc.contributor.googleauthor양세원-
dc.contributor.googleauthor김윤남-
dc.contributor.googleauthor김미선-
dc.identifier.doi10.3345/kjp.2009.52.11.1249-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00378-
dc.relation.journalcodeJ02100-
dc.identifier.eissn2092-7258-
dc.subject.keywordCost-
dc.subject.keywordCost effectiveness-
dc.subject.keywordGrowth hormone-
dc.subject.keywordQuality of life-
dc.subject.keywordRecombinant growth hormone-
dc.subject.keywordUtility-
dc.contributor.alternativeNameKim, Duk Hee-
dc.contributor.affiliatedAuthorKim, Duk Hee-
dc.citation.volume52-
dc.citation.number11-
dc.citation.startPage1249-
dc.citation.endPage1259-
dc.identifier.bibliographicCitationKorean Journal of Pediatrics, Vol.52(11) : 1249-1259, 2009-
dc.identifier.rimsid44305-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.